KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 158 filers reported holding KRYSTAL BIOTECH INC in Q4 2022. The put-call ratio across all filers is 6.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,429 | +431.5% | 20,939 | +266.5% | 0.03% | +460.0% |
| Q1 2023 | $457 | -85.1% | 5,714 | -85.3% | 0.01% | -86.5% |
| Q4 2022 | $3,072 | -98.1% | 38,774 | +1557.0% | 0.04% | +1750.0% |
| Q3 2022 | $163,000 | -88.9% | 2,340 | -89.6% | 0.00% | -87.5% |
| Q2 2022 | $1,475,000 | -43.3% | 22,470 | -42.5% | 0.02% | -15.8% |
| Q1 2022 | $2,602,000 | -29.1% | 39,101 | -25.5% | 0.02% | -5.0% |
| Q4 2021 | $3,670,000 | +34.7% | 52,470 | +0.6% | 0.02% | +53.8% |
| Q3 2021 | $2,724,000 | +11.1% | 52,182 | +44.8% | 0.01% | +18.2% |
| Q2 2021 | $2,451,000 | -15.7% | 36,041 | -4.5% | 0.01% | -26.7% |
| Q1 2021 | $2,908,000 | +12.8% | 37,750 | -12.2% | 0.02% | +7.1% |
| Q4 2020 | $2,579,000 | +5.3% | 42,988 | -24.4% | 0.01% | -12.5% |
| Q3 2020 | $2,449,000 | +186.1% | 56,879 | +175.1% | 0.02% | +128.6% |
| Q2 2020 | $856,000 | – | 20,676 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 771,250 | $53,949,000 | 4.15% |
| First Light Asset Management, LLC | 680,170 | $47,578,000 | 3.41% |
| ACT CAPITAL MANAGEMENT, LLC | 59,000 | $4,127,000 | 2.98% |
| S Squared Technology, LLC | 95,215 | $6,660,000 | 2.98% |
| Redmile Group, LLC | 1,820,898 | $127,372,000 | 2.90% |
| Soleus Capital Management, L.P. | 228,437 | $15,979,000 | 1.60% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 50,922 | $3,562,000 | 1.59% |
| Artal Group S.A. | 700,000 | $48,965,000 | 1.33% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 46,670 | $3,265,000 | 1.32% |
| Kynam Capital Management, LP | 34,816 | $2,435,000 | 1.30% |